Skip to main content
Terug
Watch Compare

Healthcare Triangle, Inc.

Datakwaliteit: 100%
HCTI
NASDAQ Services Business Services
€ 2,40
▲ € 0,04 (1,69%)
Marktkapitalisatie: 2,77 M
Prijs
€ 2,40
Marktkapitalisatie
2,77 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,18 — conservative balance sheet
Negative free cash flow of -10,51 M
Capital efficient — spends only 0,08% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-64,77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-66,77%
Onder sectorgemiddelde (-15,85%)
ROIC-39,66%
Net Margin-48,84%
Op. Margin-45,16%

Veiligheid

Debt / Equity
0,18
Onder sectorgemiddelde (0,39)
Current Ratio2,03
Interest Coverage-15,14

Waardering

PE (TTM|NTM)
-0,44 | -0,08
Boven sectorgemiddelde (-1,21)
P/B Ratio0,32
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (506 peers)
Metriek Aandeel Sector Mediaan
P/E -0,4 -1,2
P/B 0,3 1,4
ROE % -66,8 -15,8
Net Margin % -48,8 -18,3
Rev Growth 5Y % — 4,0
D/E 0,2 0,4

Koersdoel Analisten

1 analist
Hold
Huidig
€ 2,40
+12400.0%
Koersdoel
€ 300,00
€ 300,00
€ 300,00
€ 300,00
Vooruitzicht
Forward K/W -0,08
Forward WPA -€ 31,80
Omzet Sch. 24,42 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2026 -€ 31,80
-€ 31,80 – -€ 31,80
 24,42 M 1

Winstverassingen

Laatste 2 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q32025 -€ 13,20 -€ 25,20 -90,9%
Q22025 N/A -€ 34,80 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) -64,77% Revenue Growth (3Y) -49,51%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 12,94 M Net Income (TTM) -6,32 M
ROE -66,77% ROA -44,50%
Gross Margin 8267,66% Operating Margin -45,16%
Net Margin -48,84% Free Cash Flow (TTM) -10,51 M
ROIC -39,66% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,18 Current Ratio 2,03
Interest Coverage -15,14 Asset Turnover 0,91
Working Capital 4,03 M Tangible Book Value 8,54 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,44 Forward P/E -0,08
P/B Ratio 0,32 P/S Ratio 0,21
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,11 Fwd Earnings Yield N/A
FCF Yield -379,06%
Market Cap 2,77 M Enterprise Value 2,67 M
Per Share
EPS (Diluted TTM) -2,46 Revenue / Share 11,20
FCF / Share -9,10 OCF / Share -9,09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,08% FCF Conversion 166,29%
SBC-Adj. FCF -10,99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue 11,70 M 33,20 M 45,89 M 35,27 M
Net Income -5,97 M -12,34 M -9,61 M -5,95 M
EPS (Diluted) -1,13 -2,92 — -0,20
Gross Profit 1,07 B 1,07 B — —
Operating Income -4,75 M -11,35 M -10,42 M -5,36 M
EBITDA — — — —
R&D Expenses 429.000,0 799.000,0 5,95 M 5,26 M
SG&A Expenses — — 0,0 —
D&A 889.000,0 7,23 M 3,37 M 1,42 M
Interest Expense -1,21 M 968.000,0 212.000,0 566.735,0
Income Tax 12.000,0 35.000,0 63.000,0 24.246,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 1,96 M 10,05 M 20,76 M 24,61 M
Total Liabilities 7,08 M 9,51 M 8,38 M 8,48 M
Shareholders' Equity -5,11 M 538.000,0 12,48 M 16,13 M
Total Debt 2,65 M 3,43 M 2,41 M 2,21 M
Cash & Equivalents 20.000,0 1,23 M 1,34 M 1,77 M
Current Assets 1,45 M 5,73 M 7,75 M 11,80 M
Current Liabilities 7,08 M 8,12 M 6,15 M 6,25 M